Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients

ER Lepper, SD Baker, M Permenter, N Ries, Ron van Schaik, PW Schenk, DK Price, D Ahn, NF Smith, G Cusatis, RG Ingersoll, SE Bates, RHJ Mathijssen, Jaap Verweij, WD Figg, A Sparreboom

Research output: Contribution to journalArticleAcademicpeer-review

65 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)7398-7404
Number of pages7
JournalClinical Cancer Research
Issue number20
Publication statusPublished - 2005

Cite this